Clinical Trials Directory

Trials / Completed

CompletedNCT01812681

Cord Blood 25(oh)-Vitamin D Level in Preterm Infants and Associated Morbidities

Is Higher Cord Blood 25(Oh)-Vitamin D Level Preventive For Any Morbidity Including Rds, Pda, Nec, Bpd And Rop In Preterm Infants

Status
Completed
Phase
Study type
Observational
Enrollment
81 (actual)
Sponsor
Dr. Sami Ulus Children's Hospital · Academic / Other
Sex
All
Age
1 Day – 5 Days
Healthy volunteers
Not accepted

Summary

Experimental and observational studies have shown that vitamin D deficiency may be associated with an increased risk for non-bone diseases and/or abnormal development for the other systems of fetus. The aim of this study is to determine the relationship between cord blood 25-hydroxyvitamin D (25 (OH) D) concentrations and the subsequent risk of morbidities including RDS, PDA, NEC, BPD AND ROP in preterm infants.

Detailed description

It was shown that vitamin D play important role in the pathogenesis of long term morbidities of newborn. Experimental and observational studies have shown that vitamin D deficiency may be associated with an increased risk for non-bone diseases and/or abnormal development for the other systems of fetus. The aim of this study is to determine the relationship between cord blood 25-hydroxyvitamin D (25 (OH) D) concentrations and the subsequent risk of morbidities including RDS, PDA, NEC, BPD AND ROP in preterm infants.

Conditions

Timeline

Start date
2012-10-01
Primary completion
2013-10-01
Completion
2013-11-01
First posted
2013-03-18
Last updated
2014-08-15
Results posted
2014-08-12

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT01812681. Inclusion in this directory is not an endorsement.